Description
Learning Objective(s):
Describe developments and challenges in radiation oncology and medical physics in the last 5 years since ICARO 2
Discuss hypofractionation as an example of COVID-19 impact on radiotherapy practice
Eduardo Rosenblatt
16/02/2021, 08:30
Invited Presentation
Geoffrey Ibbott
(UT MD Anderson Cancer Center)
16/02/2021, 08:45
Invited Presentation
Mr
Eduardo Rosenblatt
(Radiation Oncology Consultant, Montserrat, Spain), Mr
Geoffrey Ibbott
(IOMP, University of Texas MD Anderson Cancer Center)
Invited Presentation
The session will describe the developments and challenges in radiation oncology and medical physics in the last 5 years since ICARO 2; There will be discussion of hypofractionation as an example of COVID-19 impact on radiotherapy practice
Mr
Eduardo Rosenblatt
(Radiation Oncology Consultant, Montserrat, Spain), Mr
Geoffrey Ibbott
(IOMP, University of Texas MD Anderson Cancer Center)
Invited Presentation
The session will describe the developments and challenges in radiation oncology and medical physics in the last 5 years since ICARO 2; There will be discussion of hypofractionation as an example of COVID-19 impact on radiotherapy practice
